Although conventional therapies provide satisfactory results in the treatment of acute vaginal Candidiasis, there is still interest in preventing relapse. In this study, conducted on a group of women with vaginal Candidosis the strain of Saccharomyces cerevisiae CNCM I-3856 was effective in the control of vaginal candida proliferation and in the prevention of recurrent vaginal Candidosis. This probiotic yeast is well tolerated and easy to use in oral administration
Saccharomyces cerevisiae CNCM I-3856 as Natural Breakthrough for Vaginal Health: A Clinical Study AUTHORS: Amélie Cayzeele-Decherf, Fanny Pélerin, and Peter Jüsten – Medical Journal Obstetrics and Gynecology 5(4): 1112, 21 December 2017 Vulvovaginal candidiasis (VVC) is a common and burdensome fungal infection …
The data suggest that the beneficial effects of this live Saccharomyces cerevisiae are the result of its interference with the expression of the virulence factors of Candida albicans associated with modulation of the host inflammatory response.
Saccharomyces cerevisiae-based probiotic as novel anti-fungal and anti-inflammatory agent for therapy of vaginal candidiasis Authors: Gabrielli, E. Pericolini, N. Ballet, E. Roselletti, S. Sabbatini, P. Mosci, A. Cayzeele Decherf, F. Pélerin, Expert, P. Jüsten and A. Vecchiarelli – Beneficial Microbes Article in …